Publisher Correction: Anti-AMPA GluA3 antibodies in Frontotemporal dementia: a new molecular target

Sci Rep. 2018 Jan 5;8(1):272. doi: 10.1038/s41598-017-18750-8.

¹ Neurology Unit, Centre for Neurodegenerative Disorders, Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy. bborroni@inwind.it.
² Department of Pharmacological and Biomolecular Sciences, University of Milan, Milan, Italy.
³ CNR Institute of Neuroscience and Department of Biotechnology and Translational Medicine, University of Milan, Milan, Italy.
⁴ Neurology Unit, Centre for Neurodegenerative Disorders, Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.
⁵ IRCCS Carlo Besta, Milan, Italy.
⁶ III Laboratory of Analyses, Biotechnology Laboratory, Brescia Hospital, Brescia, Italy.
⁷ Molecular Markers Laboratory, IRCCS Fatebenefratelli S. Giovanni di Dio, Brescia, Italy.
⁸ International Centre for Genetic Engineering and Biotechnology-ICGEB, Trieste, Italy.
⁹ Department of Pharmacological and Biomolecular Sciences, University of Milan, Milan, Italy. fabrizio.gardoni@unimi.it.

Abstract

A correction to this article has been published and is linked from the HTML version of this paper. The error has been fixed in the paper.